ArticleJAAD case reports2022
Rapid resolution of widespread cutaneous lichen planus and generalized pruritus in an elderly patient following treatment with dupilumab.
Article in JAAD case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.
- A systematic review of the role of interleukin inhibitors in lichen planus: therapeutic and paradoxical effects.Inflammopharmacology · 2025Pooled it
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review.Biomolecules · 2023Pooled it
- Successful treatment of chemotherapy-induced linear bullous lichen planus with dupilumab.JAAD case reports · 2026Article
- Dupilumab as a novel therapy for eruptive lichen planus in an Asian patient with metabolic syndrome.Skin health and disease · 2026Article
- Lichenoid Drug Eruption From Cetirizine Treated With Upadacitinib and Dupilumab.The Journal of clinical and aesthetic dermatology · 2026Article
- Clearance of Cutaneous Lichen Planus with Deucravacitinib.The Journal of clinical and aesthetic dermatology · 2026Article
- [Drug-induced lichen planus responsive to upadacitinib treatment].Dermatologie (Heidelberg, Germany) · 2025Article
- Efficacy of Dupilumab in a Young Woman with Refractory Cutaneous Lichen Planus: A Case-Based Review.Diseases (Basel, Switzerland) · 2025Review
- Type 2 Inflammation and Its Role in Dermatologic Diseases.International journal of dermatology · 2025Review
- Article
- Article
- Article
- Dupilumab-Induced Generalized Lichen Planus: A Case Report.Journal of inflammation research · 2025Article
- Association of lichen planus with asthma and allergic rhinitis in the All of Us Research Program: a cross-sectional study.Clinical and experimental dermatology · 2024Article
- Case report: Hypertrophic lichen planus initially misdiagnosed as squamous cell carcinoma.Frontiers in medicine · 2024Article
- Nivolumab-induced lichen planus responsive to dupilumab treatment in a patient with stage III C melanoma.JAAD case reports · 2023Article
- A Case Report and Literature Review of the Role of Dupilumab in the Management of Lichen Planus: Cause or Treatment?Cureus · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.